EMJ Podcast: Spotlight on Non-Small Cell Lung Cancer (NSCLC)

EMJ Podcast: Spotlight on Non-Small Cell Lung Cancer (NSCLC)

Bonus Episode

Spotlight on Non-Small Cell Lung Cancer (NSCLC)

In this episode, sponsored by The Janssen Pharmaceutical Companies of Johnson & Johnson, Jonathan sits down with Dr Marina Garassino, Chair of Thoracic Oncology at the National Cancer Institute of Milan, to explore the unmet needs for patients living with EGFR-mutated non-small cell lung cancer (NSCLC). They shine a light on the role played by EGFR mutations in NSCLC, the need for improved testing, and the importance of engagement of both doctors and patients for shaping clinical decisions.

EM-65492 – Date of preparation July 2021
This podcast is supported by Janssen Pharmaceutical Companies of Johnson & Johnson. The views expressed in this podcast are those of the individual speaker and do not necessarily reflect the views of Janssen Pharmaceutical Companies of Johnson & Johnson

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.